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O-H.15 HIGH-VOLUME SURGEONS
VERSUS HIGH-VOLUME HOSPITALS:
ARE BEST OUTCOMES MORE DUE TO
WHO OR WHERE?
S. B. Ross1, A. N. Igartua1, M. DeGori1, A. F. Teta1,
K. Luberice1, P. G. Toomey2, P. B. Sukharamwala1 and
A. S. Rosemurgy1
1Florida Hospital Tampa, Tampa, FL; 2University Of South
Florida Department Of Surgery, Tampa, FL
Introduction: High-volume hospitals are purported to
provide ‘best’ outcomes. High-volume hospitals and high-
volume surgeons are inextricably related. We undertook
this study to evaluate the outcomes after pancreaticoduo-
denectomy when high-volume surgeons relocate to a low-
volume hospital.
Methods: Outcomes after the last 50 pancreaticoduo-
denectomies at a high-volume hospital in 2012 were
compared to the outcomes after the first 50 pancreaticoduo-
denectomies undertaken at a low-volume (i.e., no pancrea-
ticoduodenectomies in >5 years) hospital in 2012–13. Data
are presented as median (mean ± SD).
Results: Patients undergoing pancreaticoduodenectomies at
a high-volume vs. a low-volume hospital were not different
relative to sex and age (Table). Patients operated upon at the
low-volume hospital had lower ASA class, had shorter opera-
tions with less blood loss, spent less time in the ICU, and had
shorter length of stay (p < 0.05 for each, Table); 30-day mor-
tality and 30-day readmission rates were not different
(Table).
Conclusion: The salutary benefits of being a high-volume
hospital for pancreaticoduodenectomy are transferred to a
low-volume hospital when high-volume surgeons relocate.
The ‘best’ outcomes associated with high-volume hospitals
may be primarily due to the high-volume surgeons who work
there, and the ‘best’ results follow the high-volume surgeons.
The ‘best’ results seem to be related more to who does the
pancreaticoduodenectomy rather than where the pancreatico-
duodenectomy is undertaken.
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OP-II.01 EXPRESSION OF FATTY ACID
BINDING PROTEINS IN A MOUSE
MODEL OF OBESITY-ASSOCIATED HCC
K. J. Thompson, S. S. Nazari, D. A. Iannitti,
I. H. McKillop and D. Sindram
Carolinas Medical Center, HPB Surgery, Charlotte, NC
HCC is the 3rd leading cause of cancer-related mortality. Risk
factors for HCC include viral hepatitis and chronic alcohol
consumption, with obesity emerging as an important risk
factor. The aim of this study was to investigate expression of
fatty acid binding proteins (FABPs) as potential biomarkers
of obesity-associated HCC. C57BL/6 mice were injected
with vehicle (Veh) or diethylnitrosamine (DEN; 5 mg/kg) at
21–24 d. At 5 wks, mice were placed on control diet (CD;
10% kcal%/fat) or high fat diet (HFD; 60% kcal%/fat). At
42 wks livers examined for gross tumor incidence and his-
tology performed. To assess FABP expression, RT-qPCR and
immunoblots were performed. Animals on HFD-Veh formed
large tumors in 30% of animals, an effect exacerbated by
DEN administration (90%), compared to small tumors in
60% in CD-DEN. Expression of FABP1 was upregulated in
CD-DEN and HFD-DEN compared to Veh-injected animals.
FABP2 was unchanged between CD-Veh and –DEN and
HFD-Veh animals. However; there was a 2-fold down regu-
lation of FABP2 in livers of HFD-DEN non-tumor tissue
(NT) compared to HFD-DEN tumor (T) tissue. There was
∼1000-fold upregulation of FABP4 in HFD animals com-
pared to CD animals, an effect exacerbated in DEN-injected
animals. FABP5 expression was downregulated in HFD-Veh
and HFD-DEN-NT tissue; however, HFD-DEN-T tissue
expressed 3-fold higher levels. FABPs are dysregulated in
obesity-associated HCC. Interestingly, there is a reciprocal
relationship between expression of FABPs 1, 2 and 5 in
tumor tissue from HFD-DEN mouse livers compared to NT
liver tissue. These findings suggest FABPs may be
biomarkers for obesity-associated HCCs.
OP-II.02 SURVIVAL FOLLOWING
MULTIDISCIPLINARY MANAGEMENT
OF EXTENSIVE COLORECTAL LIVER
METASTASES
J. Pasko, J. Wagner, O. Lafi, B. Sheppard, S. Orloff,
G. Vaccaro, C. Lopez and K. G. Billingsley
Oregon Health And Sciences University, Portland , OR
Introduction: Developments in surgical technique and uti-
lization of peri-operative oxaliplatin based chemotherapy
have provided the opportunity of resection to patients with
extensive colorectal liver metastases (CRLM). The aim of
this study is to assess survival and disease recurrence follow-
ing resection for patients with advanced CRLM.
Methods: This is a single institution retrospective review of
patients with colorectal liver metastases from June 2003 to
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May 2011. During the study 168 patients underwent liver
resection. This study included 28 patients with >4 liver
metastases. Survival is calculated using the Kaplan Meier
estimate. This study was approved by this institution’s IRB.
Results: The median age was 59 years, 71% were male.
Seventy-five percent had synchronous metastases at the time
of initial operation; 61% received preoperative chemo-
therapy. Operations included: trisegmentectomy 46%, lobec-
tomy 25%, segmental resection 29%. The sizes of largest
tumor ranged from 1.1 cm to 9.2 cm and median size was
3.2 cm. Positive margins after resection occurred in 39%.
Seven patients (28%) underwent a second liver resection.
Recurrent disease developed in 26 patients, 9 (35%) liver
only, 17 (65%) with extrahepatic disease. The 30 day mor-
tality was 3%. Survival at 3 and 5 years is 46% and 18%. The
overall median survival was 38 months. The median disease
free survival was 10 months. The median follow-up was 34
months.
Discussion: These results indicate few patients with exten-
sive CRLM achieve long-term cure. However, resection is
safe and most patients experience extended treatment-free
periods. High tumor number alone should not contraindicate
resection.
OP-II.03 PROSPECTIVE ANALYSIS OF
TACE AS PRIMARY THERAPY IN HCC
MANAGEMENT
K. Collins, N. Saad, N. Vachharajani, K. Fowler,
K. Korenblat, M. Doyle and W. Chapman
Washington University School Of Medicine, St. Louis, MO
Introduction: Transarterial Chemoembolization remains
first-line therapy for patients with HCC, however the effec-
tiveness of response is unknown. We conducted a prospective
analysis of TACE as primary therapy in patients with HCC
and chronic liver disease.
Methods: Between 7/1/2009 and 12/31/2012, we performed
761 TACE in 398 HCC patients. 10 cases of biphenotypic
tumors were excluded, as were 17 cases of radio-
embolization.359 were newly identified HCC cases whereas
39 were recurrent HCC who had one of the following treat-
ments in the past with complete response at that time: OLT (1
case); Resection (12 cases); RFA (1 cases); TACE (25 cases).
192 cases were outside of Milan at the time of treatment.
(Stage III – 104; Stage IVA1 – 58; Stage IVA2 – 30).
Results: 25/192 (13%) initially beyond Milan have under-
gone OLT and (4.7%) are currently listed. 5 (2.6%) patients
died while waiting on list and 1 (0.5%) needed to be taken
off-list due to disease-progression. 68 cases could not be
listed for OLT. Reasons were as follows: Disease-extent (30
(15.6%) cases), comorbidities (9 (4.7%) cases), social/
insurance/non-compliance related problems (13 (6.8%)
cases), unwilling for transplant (13 (6.8%) cases), patient
died before the evaluation was completed (3 (1.6%) cases).
Of the remaining 208 patients that came to us as Within-
Milan cases, 75 have been transplanted.
Conclusion: TACE is an effective therapy for patients
within Milan and for those beyond Milan, both for OLT
candidates and for those who may downstage to within
Milan. This has become the standard of care for HCC in
non-operative candidates.
OP-II.04 MINIMALLY INVASIVE
MICROWAVE ABLATION OF EARLY
STAGE HEPATOCELLULAR
CARCINOMA
F. Alemi, K. Specht, K. Kowdley, A. Siddique, R. Crane,
E. Hauptmann, M. Fotoohi, A. Alseidi, T. R. Biehl,
S. Helton and F. G. Rocha
Virginia Mason Medical Center, Seattle, WA
Background: Efficacy of microwave ablation (MWA) for
liver tumors has been difficult to compare given the hetero-
geneity of patient selection, therapies, and tumor types in
published studies. Herein we report our experience with
minimally invasive MWA in a singular cohort of early stage
hepatocellular carcinoma (HCC).
Methods: All patients with HCC who underwent percuta-
neous or laparoscopic MWA from 2011–2013 were retro-
spectively analyzed. Treatment decisions were based on
Barcelona Clinic Liver Cancer staging criteria after discus-
sion at a multidisciplinary tumor board. Standard power-time
parameters were utilized and imaging was obtained 30 days
post-procedure.
Results: Forty-eight HCC patients underwent MWA of 63
lesions, 33 percutaneously and 30 laparoscopically. All
patients had cirrhosis, 19 exhibited portal hypertension with
a mean Child’s score of 6.3 and MELD of 10.2. Mean tumor
size was 2.0 cm (range 0.7–3.5) with an average of 1.43
ablations/tumor. Length of stay was 1.1 days in the
laparoscopic group while all percutaneous treatments were
outpatient. There were four complications (2 pneumothorax,
1 wound infection, and 1 arrhythmia) and four local recur-
rences (6.3%; three percutaneous and one laparoscopic,
p = 0.61). Thirteen patients developed a new lesion at a mean
of 6.6 months. There was no difference in total cost between
laparoscopic or percutaneous groups ($36,508 versus
$30,510, p = 0.15). Overall survival was 87.5% with all
deaths due to end-stage liver disease.
Conclusion: MWA of early stage HCC is safe and effective
through laparoscopic and percutaneous routes. Further
studies should be focused on selecting patients who may
derive benefit and value from these approaches.
OP-II.05 LIVER RESECTION WITH
HEPATIC VEIN RECONSTRUCTION IS A
VIABLE OPTION IN SELECTED
PATIENTS
R. Smoot, J. Conneely, P. Serrano, D. Cavallucci and
I. McGilvray
University Of Toronto, Toronto, ON
Introduction: The morbidity and mortality associated with
liver resection has continued to decrease and venous recon-
struction experience has continued to increase. This allows
consideration of extended liver resection for tumors, which
includes resection and reconstruction of the major hepatic
venous outflow in selected patients.
Methods: Patients undergoing liver resection with major
hepatic venous reconstruction between the years 2005–2013
were reviewed.
Results: For the study years a total of 18 patients were
identified. Median age was 49.5 years (24–67) for 11 men
and 7 women. The pathology included colorectal cancer
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(7 patients), cholangiocarcinoma (6 patients), sarcoma
(3 patients), hepatocellular carcinoma (1 patient), and
perivascular epitheliod tumor (1 patient). Resection included
the inferior vena cava in 8 patients, and 7 patients underwent
reconstruction with ringed PTFE grafts. The venous outflow
reconstruction included left hepatic vein (LHV) to graft (4
patients), LHV to cava (3 patients), Right hepatic vein (RHV)
to graft (3 patients), RHV to cava (4 patients), middle hepatic
vein (MHV) to cava (1 patients), RHV and MHV to cava (1
patient), MHV reconstruction with vein patch (1 patient), and
LHV reconstruction with vein patch (1 patient). Perioperative
mortality was 6% (1 patient) and a complication rate of 78%
(14 patients). Six patients had died at the time of last follow-
up, four of those patients with tumor recurrence. The cohort
had a median overall survival of 15.4 months.
Conclusion: In highly selected patients resection and recon-
struction of the major venous outflow can be completed with
reasonable morbidity and mortality.
OP-II.06 NOVEL RADIOFREQUENCY
ABLATION SYSTEM INCORPORATING
MAGNETIC TRACKING IN PORCINE
MODEL
M. Brown, M. A. Cassera, W. Johnston and C. W. Hammill
Hepatobiliary And Pancreatic Surgery Program, Portland,
OREGON
Introduction: Ultrasound-guided laparoscopic
radiofrequency ablation (RFA) requires advanced skills in
hand-eye coordination and spatial positioning. The objective
of this study was to assess whether a novel magnetic tracking
device (MTD), providing real time three-dimensional guid-
ance on a stereoscopic monitor, increases proficiency over
ultrasound guidance alone.
Methods: Fiducial markers were placed at three points in the
liver of a live porcine model. Two surgeons targeted the markers
using the MTD in conjunction with ultrasound, and under ultra-
sound guidance alone. The markers were targeted with the RFA
needle in-line with the ultrasound, off axis 45-degrees from the
ultrasound, and off axis 90-degrees from the ultrasound.
Results: The times for each trial are summarized in Table 1.
Discussion: Surgeon #1 showed a decreased time to target
the marker with the MTD over ultrasound alone when the
target was approached from out-of-plane, with a larger
impact at 90 degrees. In addition, time with the MTD
decreased as they became more familiar with it. Surgeon #2
showed a decrease in time taken to target the marker with the
MTD when in-plane and 90 degrees out-of-plane, but did not
show a clear benefit when 45 degrees out-of-plane. The use
of the MTD did not show a clear benefit. However, for both
surgeons, the use of the MTD decreased the amount of time
it took to accurately target the marker when the RFA probe
was 90 degrees out of plane with the ultrasound. This is
classically the most difficult method used for targeting.
OP-II.07 PATTERNS OF RECURRENCE
FOLLOWING MARGIN-POSITIVE
RESECTION OF COLORECTAL LIVER
METASTASES
C. W. Michalski, J. Wagner, B. Sheppard, S. L. Orloff,
G. Vaccaro, C. Lopez and K. G. Billingsley
Oregon Health And Science University, Portland, OR
Introduction: Positive surgical margins remain a persistent
problem in liver resection for colorectal liver metastases
(CRLM). The aim of this study was to define the patterns of
recurrent disease in patients with positive margins following
hepatectomy.
Methods: This is a retrospective analysis of prospectively
collected data for hepatectomies for CRLM performed at our
institution (2003–2012). The study population is limited to
patients with microscopic positive margins. Survival is cal-
culated using the Kaplan-Meier estimate. The study is
approved by the OHSU IRB.
Results: Out of 196 hepatectomies for CRLM, 21 patients
with a positive resection margin were identified. Twenty of
these patients had received neoadjuvant chemotherapy. The
median number of liver metastases per case was 4 and the
average size of the largest metastasis was 4 cm. Concomitant
intraoperative radiofrequency ablation was performed in 6
cases. Median overall survival following liver resection was
39 months and median disease-free survival was 12 months.
4 patients recurred in the liver only. Of the liver only recur-
rences only one patient had disease limited to the site of
resection. In 15 patients, either distant metastasis, liver and
distant recurrence, or liver recurrence followed by shortly
afterwards distant recurrence was found (one patient did not
recur and one patient was lost to follow-up).
Conclusion: Although surgeons must aim for negative
margins, these results suggest that most patients with positive
margins have unfavorable disease biology and their greatest
risk is systemic recurrence. Additional therapy, such as radia-
tion to the involved margin is unlikely to add to survival in
patients with positive margins.
OP-II.08 THE SLIPPERY SLOPE OF
CROSS CLAMPING VS OPEN SURGERY:
IS THE CHOICE OBVIOUS?
T. Dominioni, J. Viganò, L. Cobianchi, A. Peloso,
J. Ferrario, A. D’addiego, I. Benzoni, P. Dionigi and
M. Maestri
Fondazione IRCCS Policlinico San Matteo, Pavia, PV
Liver resection is the best chance of cure for primary and
metastatic liver cancers. Extreme liver surgery has been
proven feasible when the remaining parenchyma is sufficient
to support metabolic needs and the stress of liver regenera-
tion. Intermittent cross clamping is used to decrease the risk
of excessive blood losses in liver surgery. 89 patients under-
went major liver surgery between January 2009 and January
2012. Such cases were enrolled in a study to evaluate the
effect of intermittent cross clamping (CC) of the liver hilum
vs. open flow surgery (OF) . Patients where assigned to group
1 (n = 50, CC) and group 2 (n = 39, OF). Blood losses, hos-
pital stay, postoperative liver function and complications
were evaluated. Statistical analysis was performed by non
parametric techniques. Survivals were compared by Kaplan
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Meier curves and post-hoc tests. All the patients survived and
were discharged within the 14th POD. Blood losses were
lower in the CC group compared to OF (p < 0.05). However,
the CC group showed a significant increase of LFTs after
surgery, from the 1st POD to the 5th. While all cases recovered
to normality, hypoxia was the key factor to determine this
observation. Survival analysis did not demonstrate any sig-
nificant difference between CC and OF. The onset of com-
plications was remarkably similar in both groups. While
survivals do not differ, the use of cross clamping should be
carefully evaluated and its use reserved to cases with special
technical difficulties.
OP-II.09 TREATMENT RESPONSE OF
HEPATOCELLULAR CARCINOMA BY
ETIOLOGY OF LIVER DISEASE
R. M. Seshadri, D. J. Niemeyer, J. Lee, R. Z. Swan,
D. Sindram, J. B. Martinie, M. Russo and D. A. Iannitti
Carolinas Medical Center, Charlotte, NC
Introduction: In the US, HCC is usually associated with
Cirrhosis from either Alcohol; hepatitis C (HCV) or Nonal-
coholic Fatty Liver Disease (NAFLD). Therapy while waiting
for transplant includes transarterial chemoembolization
(TACE), microwave ablation (MWA), radioembolization
using Yttrium 90 and Sorafenib. Our aim was to determine if
there is an association between etiology of cirrhosis and
treatment response to MWA and TACE for HCC.
Methods: Retrospective analysis was performed from our
patient database and 332 patients were reviewed of which
118 of them were found to have HCC. 71 patients developed
HCC from HCV and 21 patients from NAFLD. The first
CT/MRI after treatment was reviewed using the RECIST
(response evaluation criteria in solid tumors) criteria. We
compared RECIST response, 1 year mortality, type of treat-
ment and demographic data between the 2 groups.
Conclusion: NAFLD patients with HCC had higher
response rates to locoregional therapy but our sample size
may have been too small to demonstrate statistical signifi-
cance. The HCV group was younger compared to the
NAFLD group and the NAFLD group was more likely to
have high AFP. Further study is warranted because these
findings may have implications of when to initiate screening
and utilize AFP based upon etiology of liver disease.
OP-II.10 REDUCUCTION OF
COMPLICATIONS: THE PROGRESSION
OF LAPAROSCOPIC LIVER RESECTION
A. Hauch, S. Lee, A. Golden, E. Kane, E. Kandil and
J. Buell
Tulane Transplant Institute, New Orleans, LA
Introduction: Laparoscopic hepatic resection has been
described as safe and efficacious. This study examines the
drift in incidence and severity of post-operative complica-
tions arising from laparoscopic compared to open liver
resection.
Methods: Retrospective review of 615 patients managed by
a single surgeon from 2000 to 2013. Analysis contrasts the
demographics and post-operative outcomes between both
groups. Complications were examined and compared using
the Clavien-Dindo Classification for severity.
Results: 753 hepatic resections in 615 patients were exam-
ined. Open surgery was reserved for smaller lesions (4.5 vs.
5.1 cm: p = 0.064) and predominately in malignant lesions
(44.8 vs. 78.2%: p < 0.001). Complications were more fre-
quent in open procedures (40.2 vs. 20.2%: p < 0.001)
although the severity of complications was not significantly
different (p = 0.846). Concordantly an open approach
resulted in a higher percentage of patients requiring critical
care (89.7 vs. 12.9%: p < 0.001) resulting in a longer hospi-
talization (8.5 vs. 3.4 days: p < 0.001).
Conclusion: This study confirms laparoscopic hepatic
resection carries a lower incidence of complication. Notably
the severity of the complications is equivalent between the
laparoscopic and open groups. The higher utilization of criti-
cal care services and prolonged hospitalization may also be
attributed to an increased complexity of open resections not
performed laparoscopically.
OP-II.11 AN ENHANCED RECOVERY IN
LIVER SURGERY (ERILS) PATHWAY FOR
MINIMALLY INVASIVE AND OPEN
HEPATIC RESECTION DEMONSTRATES
EARLIER RETURN TO NORMAL
FUNCTION AND INTENDED
ONCOLOGIC THERAPIES
T. A. Aloia, A. Cooper, C. Conrad, J. Vauthey and
V. Gottumukkala
UT MD Anderson Cancer Center, Houston, TX
Background: Although multiple fast-track and enhanced
recovery (ER) pathways are currently being evaluated in
abdominal surgery, few have focused on the benefits of ER in
liver surgery and no studies have evaluated the impact of ER
on return to intended oncologic therapies.
Patients/Methods: Short-term outcomes for patients
managed with an ERILS pathway (preoperative education,
non-narcotic premedication, epidural catheter for open
approach, and postoperative multimodality non-narcotic
analgesia) were prospectively recorded. Milestones includ-
ing length of stay, time to return of baseline performance
status and to intended oncologic therapies were compared to
historical norms.
Results: Between June-September 2013, 11 patients were
treated with ERILS. The median age was 58 years (range:
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42–74), and 7 (63.3%) were male. Indications included 3
HCC/Cholangio, 5 colorectal metastases and 3 other metas-
tases with median tumor number of 1 (range:1–2) and
median tumor size of 4.0 cm (range:1.3–8.5 cm). Resection
approaches and procedures included 4 minimally invasive
(MIS), 7 open and 5 major hepatectomies. The median
lengths of stay (LOS) for the MIS and open groups were 2.3
days and 4.3 days, respectively, with one complication
(urinary retention) and no readmissions. The median time to
return to baseline function was 12 days and the median time
to reinitiation of intended oncologic therapy (RIOT) was 24
days. These benchmarks compare favorably to historical MIS
LOS (3.2 days), Open LOS (6.4 days), and RIOT times
(34 days).
Conclusion: This early experience with a narcotic-sparing
ERILS pathway demonstrates safety, feasibility and encour-
aging reductions in time to return to normal activity and to
intended oncologic therapies.
OP-II.12 COST EFFECTIVE ANALYSIS OF
ALTRUS VERSUS CUSA FOR LIVER
RESECTIONS
G. R. Beck, K. P. Croome and R. Hernandez-Alejandro
University Of Western Ontario, London Health Science
Centre, London, ONTARIO
Various techniques are available for hepatectomy parenchy-
mal division including “clamp-crush”, electrocautery, ultra-
sonic or waterjet ablation, staplers and tissue sealing/fusion/
cutting devices from different energy sources. Each have
advantages/disadvantages leading to equivocal best method
for hepatectomy. With limited data, studies have failed to
demonstrate benefit of these technologies over “clamp-
crush”. We report the first use of a novel tissue thermal fusion
device ALTRUS(CONMED) in a retrospective comparison
to our standard of CUSA for hepatectomy. From January
2010 to August 2013, single surgeon, 120 patients analyzed
and after exclusions, ALTRUS (n = 49) and CUSA (n = 53)
compared. Both groups were comparable with respect to age,
gender, ASA, indication for resection (mainly CRC). The
ALTRUS group had fewer segments resected (more paren-
chymal preservation), with similar number liver lesions in
both groups. In the ALTRUS group, operating room time
was significantly shorter (minutes, 220.5 ± 92.2 vs.
324.4 ± 113.5, p < 0.001). There was less calculated blood
loss (cc, 376.1 ± 399.1 vs. 710.8 ± 663.2, p = 0.01), less
transfusions intraoperatively (units PRBC, 0.34 ± 1.41 vs.
1.45 ± 2.50, p = 0.02) and total in hospital stay (units PRBC,
0.53 ± 1.46 vs. 2.34 ± 3.28, p = 0.004). Accounting for
quicker OR time and equipment, cost was significantly less
(CAN$, 5764.20 vs. 8066.20, p < 0.001) excluding surgical
billings. Resection margin and hospital stay were similar.
This retrospective comparison of the novel ALTRUS demon-
strates it is faster, less expensive to the health care system,
efficient and oncologically safe. It permits more parenchymal
preservation. Given its novelty, other studies(including basic
lab) may be warranted to formalize its safety and efficacy.
OP-II.13 IMMUNOHISTOCHEMICAL
TUMOR MARKERS IN THE
DIAGNOSTICS OF FOCAL LIVER
LESIONS
J. Vilmanis, I. Strumfa, A. Ozolins, R. Stucka and
J. Gardovskis
Pauls Stradins Clinical University Hospital, Riga, RIGA
Introduction: Correct diagnosis is mandatory for treatment
of primary or secondary liver tumors. In most cases, biopsy is
considered the gold standard. The aim of the present study
was to evaluate the role of selected immunohistochemical
tumor markers in the diagnostics of focal liver lesions.
Materials and methods: Sequential patients presenting
with focal liver lesions were enrolled in the study. The clini-
cal history and radiological findings were reviewed. Biopsy
and/or operation material were examined by routine
histology followed by immunohistochemical visualization
of alpha-fetoprotein (AFP), TTF-1, hepatocyte antigen
(HepPar), CD10, cytokeratin (CK)7, CK20, CDX2, mam-
maglobin, chromogranin A and prostate specific antigen.
Results: In total, 71 patients, aged 22–86 years (mean, 61.9)
were enrolled. The final diagnosis of hepatocellular carci-
noma (HCC) was established in 17 cases and of metastatic
colorectal cancer (mCRC) – in 12 cases. In addition, meta-
static lung cancer (3) and neuroendocrine tumours (2) were
diagnosed. Metastatic pancreatic cancer (6) and
cholangiocarcinoma (4) were suspected; however, no definite
molecular proof was reached in these cases. The panel
including HepPar, TTf-1 and AFP allowed diagnosing all
cases of HCC by showing positivity of at least 1 marker.
CDX2 in combination with expression of CK20 and negativ-
ity for CK7 was informative in all mCRC cases. Benign
conditions were diagnosed in 9 cases.
Conclusions: Tissue evaluation in conjunction with tumor
marker analysis can provide useful diagnostic information.
HCC can be reliably diagnosed with panel including HepPar/
TTF-1/AFP, but mCRC – by CDX2/CK20. Additional new
markers are necessary to diagnose cholangiocarcinoma and
pancreatic cancer.
OP-II.14 LAPAROSCOPIC MANAGEMENT
OF CYSTIC DISEASE OF THE LIVER
A. Hauch, S. Lee, E. Kane, E. Kandil and J. Buell
Tulane Transplant Institute, Tulane University School Of
Medicine, New Orleans, LA
Introduction: Cystic disease of the liver can occur in isola-
tion or in combination with polycystic disease of the kidney.
The treatment of symptomatic cysts has evolved from an
open surgical procedure to a laparoscopic approach.
Methods: Retrospective review of 58 patients managed by a
single surgeon from 2000 to 2013. Analysis was performed
to compare and contrast with the previously reported Pitts-
burgh series.
Results: Surgically resected patients underwent either sub-
total cystectomy or a total resection for lesions with suspi-
cious cyst linings. Median age was 61 years of age, BMI of
27, with 19% being obese (>35), with an ASA of 3. The
median cyst size was 10.8 cm. In the 54 laparoscopic
patients, 42% underwent major hepatic resection (formal
lobe) with a median resection of 3 segments in the full
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cohort. Resection required hand-assist in 60% of cases with
a median operative time of 120 min, 100 cc blood loss and 12
staple loads. Five cystadenomas were encountered. Four
cases early in the cohorts experience were approached via an
open technique for suspected cystadenoma and complexity.
Incidence of complications was 11% (bile leak n = 3, pulmo-
nary n = 2, ileus n = 2).
Conclusion: This experience confirms laparoscopic resec-
tion is the gold standard for the management of hepatic cysts.
In our experience open resection was rapidly abandoned for
laparoscopy. An early incidence of bile leak was identified
and addressed by deployment of staplers for cyst wall
transection. Both series confirm a laparoscopic approach
can be utilized with a low incidence of complications and
recurrence.
OP-II.16 WHEN SURGICAL SHUNTING IS
THE BEST OR ONLY OPTION: A CASE
SERIES
L. M. Louwers1, V. Raofi2, S. Cohn2 and A. Koffron2
1Henry Ford Health System, Detroit, MICHIGAN;
2Beaumont Health System/Oakland University School Of
Medicine, Royal Oak, MICHIGAN
Background: Surgical portosystemic shunting (PSS) has
become a less frequently used modality for control of portal
hypertension (PHTN) in the era of transjugular intrahepatic
portosystemic shunting (TIPS). In certain instances,
however, TIPS may not be anatomically feasible or the best
long-term management strategy.
Objectives: To present a series of patients highlighting sce-
narios where surgical PSS may have a more favorable
outcome compared to TIPS placement or medical manage-
ment, reinforcing the role of surgical shunting in the post-
TIPS era.
Methods: A retrospective review of surgical PSS performed
at a tertiary care center from 2009–2011.
Results: Six cases were selected to highlight circumstances
wherein surgical shunting was the preferred or only available
modality in complicated benign disease states. The underly-
ing etiologies of PHTN included nodular regenerative
hyperplasia, polycystic liver disease, chronic pancreatitis,
non-alcoholic steatohepatitis, and alcoholic pancreatitis with
left-sided PHTN. Detailed preoperative and operative
descriptions provide enhanced understanding of the benefits
of PSS in these situations.
Conclusion: In this series, we highlight two groups where
surgical shunting may still be the preferred, and in some
cases the only approach. The first group is patients who will
need long term patency of their shunt given the fact that they
are either well compensated cirrhotics or have non-cirrhotic
portal hypertension. The second, and probably more impor-
tant, are the patients with underlying aberrant anatomy which
precludes or cannot be completely addressed by TIPS place-
ment. We hope that by presenting these cases, we have
reinforced the need to consider surgical shunting in appro-
priately selected patients.
OP-II.18 EPIDEMIOLOGY OF
METASTATIC COLON CANCER AMONG
SAUDIS
F. Al-alem1, E. Simoneau2, T. A. Traiki1, N. Al-malki1,
K. Alkhayal1, A. Zubaidi1, O. Obaid1 and M. Hassanain1,3
1Department Of Surgery , King Saud University, Riyadh,
CENTRAL; 2Department Of Surgery , McGill University
Health Center, Montreal, QUEBEC; 3Department Of
Oncology , McGill University Health Center, Montreal,
QUEBEC
Introduction: The incidence of colorectal cancer in Saudi
Arabia is rising, being the most common cancer in the male
population. However, little is known about the epidemiology
of metastatic colon cancer. The country has a population of
over 26 M people with a median age and life expectancy of
25 and 75 years old respectively. Our study aim is to present
the incidence and management patterns of metastatic
colorectal cancer in Saudi Arabia.
Methods: A retrospective analysis of prospectively col-
lected data was done using the Saudi Cancer Registry (SCR)
for colorectal cancer with focus on our representative tertiary
care center, between 2006–2009.
Results: In 2008, SCR reported 904 cases with male pre-
dominance. The median age was 59 , 29.2% of patients had
synchronous disease. At our tertiary center, there were 191
new colon cancer cases with male predominance (57%) and
a mean age at diagnosis of 58. Median follow up was 3 years.
Rectal cancer was the primary site in 33% of cases. 64 (33%)
patients had synchronous disease 39(20%) were hepatic and
23 (12%) were lung metastasis. Total 15 follow up patients
had metachronous disease 7% hepatic and 4% was lung. Out
of the total liver metastasis 20% were resected.
Conclusion: Metastatic colon cancer is a considerable
problem occurring in a relatively young population. More
effective screening, possibly at an earlier age with
population-specific guidelines, and better treatment strat-
egies are needed to improve this important public health
burden.
OP-II.19 MALIGNANT MASQUERADE OF
PET-CT AVID HEPATIC ADENOMA
F. Alemi, T. Mohammed, P. Sicuro, K. Kowdley,
A. Siddique, A. Alseidi, T. Biehl, S. Helton and F. Rocha
Virginia Mason Medical Center , Seattle, WA
Background: Positron emission tomography-computed
tomography (PET-CT) can be a useful adjunct imaging
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modality to help differentiate malignant from benign liver
lesions. Known false positive lesions on PET imaging
include focal steatosis or hepatic abscesses. However, eight
cases of PET-avid hepatic adenomas have been published in
the literature. We describe our experience with this condition
and report our outcomes.
Methods: All patients who underwent evaluation for
hepatic malignancy from 1995-present with PET imaging
were reviewed focusing on patient presentation, imaging,
pathology and outcome.
Results: Two patients were identified with PET-avid hepatic
adenomas (see Figure). A 53 year-old woman with a history
of breast cancer and BRCA2 mutation developed a 2 cm
mass in segment 5 on surveillance imaging. PET-CT scan
showed a lesion with a standardized uptake value (SUV) of
10.7. Subsequent percutaneous biopsy revealed a hepatic
adenoma (negative beta-catenin staining). A 49 year-old
woman who developed abdominal pain was found to have a
4 cm juxtacaval lesion in segment 7 with liver atrophy. The
lesion was indeterminate with standard imaging and PET-CT
scan showed a lesion with an SUV of 4.9. Given concern for
malignancy, she underwent right hepatectomy and pathology
was consistent with well-differentiated hepatic adenoma with
negative beta-catenin staining but positive HNF1alpha muta-
tion. Both patients are doing well with no progression or
recurrence.
Conclusion: Despite its rarity, hepatic adenomas may dem-
onstrate PET-CT activity. Clinicians should consider this
benign etiology in young women with PET-avid liver lesions
and pursue further diagnostic tests if indicated prior to
intervention.
OP-II.20 MELD PREDICTS MORTALITY
IN CONSERVATIVELY MANAGED
CIRRHOTICS WITH PNEUMATOSIS
F. Karipineni, J. Pang, A. Parsikia and J. Ortiz
Albert Einstein Medical Center, Philadelphia, PA
Introduction: Pneumatosis intestinalis (PI) is a radiologic
finding associated with multiple conditions and a high mor-
tality rate. This is the first study addressing the management
of PI in cirrhotics. While conservative treatment is an
accepted approach to PI in the general population, it is
unknown whether the same is true when treating cirrhotics.
Methods: We retrospectively identified cases of PI found on
computed tomography (CT) scans performed on cirrhotics
from 2004–2011. Chart review included comorbidities, hos-
pital course, trends in serum lactate levels, APACHE scores,
MELD scores (Table 1). Ten cirrhotics with PI were identi-
fied. Nine were managed conservatively. One patient under-
went exploration and died.
Results: In total, in-hospital mortality was 70%. The mean
MELD in patients who died was higher than in those who
survived (28.6 vs. 14.0). Mortality was 100% in cirrhotic
patients with PI whose MELD was greater than 16. Mean
serum lactate levels (91.4 mg/dL vs 20.8 mg/dL) and mean
APACHE scores (28.3 vs. 15.3) were also higher in patients
who died. Serum white blood cell count and bicarbonate
were not consistently abnormal in those who died.
Conclusion: Our results suggest that MELD and APACHE
scores and lactate levels are important predictors of mortality
in cirrhotics with PI. Given the high risk of surgical mortality
and the natural course of PI in our population, surgical inter-
vention may be futile in cirrhotics with a MELD score
greater than 16. Larger studies are required to determine
whether there is a role for surgery in cirrhotics with lower
MELD scores.
OP-II.23 PANCREATICODUODENECTOMY
IN THE OLDEST OF OLD: RESULTS
BEYOND OPERATIVE MORTALITY
R. C. Langan1, P. R. Bucciarelli1, W. Chapman1, K. Oza1,
C. Fehring1, P. G. Jackson1, T. M. Fishbein1, R. Jha2,
N. Haddad2, F. Al-Kawas2, J. Carroll2, J. Hanna1,
A. Parker1, W. B. Al-Refaie1 and L. B. Johnson1
1Department Of Surgery: Georgetown University Hospital,
Washington, DC; 2Department Of Gastroenterology:
Georgetown University Hospital, Washington, DC
Introduction: The projected expansion of the oldest old
(≥80 years) will have significant implications on patients,
providers, hospital service lines and payers.
Methods: Perioperative outcome measures were compared
between 33 patients (≥80 years) and a non-randomized
cohort of 33 patients less than 70 years who underwent
pancreaticoduodenectomy between 2005 and 2013.
Results: Median age was 62 years (range, 34–70) and 83
years (range, 80–87) respectively. Pathology (young vs.
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elderly) included pancreatic ductal adenocarcinoma (21/33
vs. 20/33), duodenal carcinoma (0/33 vs. 2/33), ampullary
carcinoma (2/33 vs. 3/33), cholangiocarcinoma (1/33 vs.
2/33), pancreatic neuroendocrine tumor (2/33 vs. 2/33) and
benign lesions (7/33 vs. 4/33). Median tumor size (young vs.
elderly) was 2.8 cm and 3.25 cm, respectively. The mean
estimated blood loss in the young vs. elderly group was
485 mL vs. 567 mL (p = 0.42). There were no differences in
30-day operative mortality, overall perioperative complica-
tions (12/33 vs. 15/33) or 60-day re-admission rates (8/33 vs.
8/33). However, the oldest old experienced longer hospital
stays than their younger counter parts (13.7 vs. 8.4 days,
p = 0.007) and were more likely to be discharged to a skilled
nursing facility or sub-acute rehabilitation compared to home
(0/33 vs. 9/33, p = 0.002).
Conclusion: Despite their comparable operative mortality
and adverse events, the oldest old experienced higher rates of
prolonged length of stay and discharge to a skilled facility.
These results have future research and policy implications to
overcome some of the challenges of this growing cohort of
the US population.
OP-II.24 ANALYSIS OF PATENCY RATES
IN PORTOMESENTERIC VENOUS
RECONSTRUCTION DURING
PANCREATIC RESECTION
M. Brown
Providence Portland Medical Center, Portland, OREGON
Introduction: In this study, we sought to evaluate our
experience with portomesenteric venous reconstruction
(PMVR) and long-term durability.
Methods: From May 2007 to June 2012, 33 cases were
identified in which PMVR’s was performed at out Institution.
Our analysis focused on long-term patency, interval between
reconstruction and thrombosis or significant stenosis,
requirement of salvage procedure.
Results: 33 patients with en bloc pancreatic resections also,
required PMVR. 24 (72.3%) patients had pancreatic adeno-
carcinoma, 4 (12.1%) neuroendocrine tumor and other
neoplasms. Reconstructive techniques included lateral
venorrhaphy (14) (42%), primary end-to-end anastomosis
(11) (33.3%), venous interposition graft (Left internal jugular
vein harvest) (2) (6%), Bovine pericardial patch (6) (18.2%).
A vascular surgeon assisted with 7 of the 33 cases. Outcomes
focused on long-term patency, interval between reconstruc-
tion and thrombosis or significant stenosis, requirement of
salvage procedure. Early <3 months, intermediate 3–12
months and late >12 month patency rates were analyzed,
which are 87.8%, 75%, 42.4% respectively. 13 (39%) deaths
occurred over the duration of our study.
Discussion: Results of this study are consistent with most
recent published literature on PMVR with respect to patency
rates and survival. Our data suggests that early thrombosis/
stenosis which ultimately resolve is less likely due to tech-
nical error.
OP-II.25 TIME TO ADJUVANT THERAPY
FOR LAPAROSCOPIC PANCREATIC
RESECTION
T. Sachs, M. Cooper, T. Pawlik, M. Choti, L. Zheng,
J. Herman, D. Laheru, J. Cameron, C. Wolfgang,
M. Makary and M. Weiss
JOHNS HOPKINS MEDICAL INSTITUTION, Baltimore,
MARYLAND
Background: The laparoscopic approach is being increas-
ingly applied to pancreas surgery, however the oncologic
advantage remains undefined.
Methods: We performed a retrospective analysis on patients
who underwent upfront pancreatic resection for pancreatic
cancer (2009–2012). We compared demographics,
perioperative variables, time-to-adjuvant therapy (median ±
IQR) and survival between open (O) and laparoscopic (L)
surgery goups.
Results: We identified 226 patients (L:25 laparoscopic,
O:201). There were no differences in demographics or
comorbidities between groups. The majority underwent
pancreatoduodenectomy (L:76%, O:80%; P = .64), and were
stage IIB upon resection (L:64%, O:73%; P = .28). Margin
positivity was less, but not significant (L:8%, O:22.4%;
P = .09). Only 62% of patients ultimately received adjuvant
therapy (L:56%, O:63%; P = .56). Median time-to-adjuvant
therapy was less, but not significant (L:45 ± 32, O:54 ± 19
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days; P = .81). When comparing more recent patients, (after
2011), this gap widened (L:39 ± 37, O:55 ± 22; P = .47).
More laparoscopic patients received adjuvant therapy within
6 weeks of surgery (L:72%, O:52%; P = .05). Within the
study period, 37.2% of patients died (L:44%, O:36.3%;
P = .45), with similar median survival (L:288 ± 236,
O:314 ± 319 days; P = .88). Open operations had far greater
overall complications (L:24%, O:70%; P = .01), and major
wound complications (L:4%, O:24%; P = .02). Among
patients with no complications, median time-to-adjuvant
therapy (L:43 ± 29, O:50 ± 16 days; P = .27) was less, but
did not achieve significance.
Conclusion: Laparoscopic patients have fewer wound com-
plications, and less overall morbidity. While gains are being
made in time-to-adjuvant therapy, more patients and a
broader understanding of the advantages of laparoscopy
within the medical community are necessary if we are to
attain oncologic benefits.
OP-II.26 IMPACT OF
MULTIDISCIPLINARY
HEPATO-PANCREATO-BILIARY CASE
CONFERENCE ON THE MANAGEMENT
OF PANCREATIC CANCER
K. Mayer1,2, Y. Kuo2,3, J. M. Davis1,2, A. Adams1,
O. Cabasso1,3, J. J. Vernick1,2 and E. J. Hagopian1,2
1Department Of Surgery, Jersey Shore University Medical
Center , Neptune, NJ; 2Department of Surgery, Robert
Wood Johnson Medical School, New Brunswick, NJ;
3Office Of Academic Affairs, Jersey Shore University
Medical Center, Neptune, NJ
Background/Aim: Prospective case discussion allows for
the dissemination of the best practices in patient care. The
aim of this study was to determine if the initiation of a
monthly Multidisciplinary Hepato-Pancreato-Biliary (HPB)
Case Conference has influenced the approach of the initial
method of tissue diagnosis of pancreatic cancer at our
institution.
Methods: All patients initially diagnosed with pancreatic
cancer at our institution between 2007–2012 were queried
from the Tumor Registry. Patient charts were reviewed for
demographic and clinical information. Patients were classi-
fied as resectable, locally advanced/unresectable, or meta-
static at the time of presentation. The method of initial tissue
diagnosis was determined. The HPB Case Conference log
was queried for the number and type of cases presented. Data
was analyzed using Chi-square.
Results: Since 2010, a total of 116 cases, including 42 pan-
creatic cases, have been presented during the Multidiscipli-
nary HPB Case Conference. A total of 171 pancreatic cancer
cases, including 91 female and 80 male, diagnosed between
2007–2012 were identified from the Tumor Registry. When
comparing the three-year time frame prior to (2007–2009)
and after (2010–2012) the initiation of the HPB conference,
there was a significant increase in the use of a surgical or
EUS approach for resectable pancreatic cancer (P = 0.03),
EUS approach for locally advanced/unresectable (P = 0.03),
and metastatic biopsy site approach for metastatic (P = 0.02)
as compared to other methods as the initial method of tissue
diagnosis.
Conclusion: The initiation of the Multidisciplinary HPB
Case Conference has positively influenced patient care and
physician practices at our institution.
OP-II.28 IS THERE A JULY EFFECT FOR
HPB CASES?
S. Patel, S. Cheek, T. Winston, H. Osman and
D. Jeyarajah
Methodist Dallas, Dallas, TX
Background: The presence of a “July Effect” has an
increased propensity to negatively affect patient care have
been widely debated. However, there are no studies looking
at the July phenomenon related to surgical HPB fellowship.
This study aims to evaluate if there is a “July Effect” in
pancreatic cases in HPB fellowship.
Methods: Retrospective analysis from 2006–2012 was
conducted for pancreaticoduodenectomies (PD) and
laparoscopic distal pancreatectomies (LDP) performed in
July/August (group A) and April/May (group B). Intra-
operative and postoperative parameters were compared.
Variables were compared using 2 sample t test, Wilcoxon-
Mann-Whitney test, and Fisher exact test.
Results: 93 Pancreaticoduodenectomies (PD) and 18
Laparoscopic distal pancreatectomies (LDP) were conducted
during the time frames stipulated. See Table.
Conclusion: This is the first study to show a “July effect” in
PD with regards to operative time. However, there was no
difference in oncologic parameters examined, validating the
lack of impact on quality of care. LDP, on the other hand, did
not show such an effect. One possibility is that there is a
steeper learning curve in LDP.
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OP-II.29 THE USE AND UTILITY OF
ABDOMINAL CT SCANS IN THE
IMMEDIATE POSTOPERATIVE PERIOD
FOLLOWING PANCREATIC
RESECTIONS
S. Zenoni1, P. Veldhuis 1, S. Eubanks1,
S. G. De La Fuente1,2 and P. Arnoletti1,2
1Florida Hospital Orlando, Orlando, FL; 2University Of
Central Florida, Orlando, FL
Background: Pancreatic resections are associated with sig-
nificant morbidity and re-admission rates. Abdominal com-
puterized tomography (CT) scans are often obtained in the
immediate postoperative period to rule out potential compli-
cations. We sought to analyze the frequency and indications
of postoperative abdominal CT scans among pancreatectomy
patients in an attempt to elucidate the true impact of such
diagnostic imaging studies on clinical management.
Methods: A prospectively maintained database of all con-
secutive patients undergoing pancreatic resections during a
10-month period was reviewed. Patients that had undergone
a CT scan during the immediate 30-days postoperative period
were included. Outcome variables included type of CT scan
performed, indication for CT scan, resultant modification in
clinical care (drain placement, dietary modifications, antibi-
otic therapy, surgical re-intervention), length of hospital stay
and readmission rates.
Results: A total of 62 patients underwent pancreatic resec-
tions during the study period. Median length of hospital stay
for that cohort was 10 days. Hospital re-admission rate was
30%. Postoperative abdominal CT imaging was obtained in
48% (n = 30) patients at an average time interval of 11.3 days
following surgery. Postoperative CT imaging led to insertion
of a percutaneous drain in 11% of patients and surgical
re-intervention in 5% of patients. There were 76% of patients
with unremarkable CT findings.
Conclusion: Postoperative CT scans seldom result in clini-
cally significant interventions and are over-utilized following
pancreatic resections. Abdominal imaging in pancreatectomy
patients should be selectively employed to avoid the
increased cost and potential harmful consequences of
repeated radiographic studies.
OP-II.30 GROOVE PANCREATITIS: A
RARE MIMICKER OF PANCREATIC
CANCER WHICH CAN BE TREATED
WITH PANCREATICODUODENECTOMY
S. Rabi, J. Cameron, M. Makary, K. Hirose, N. Rezaee,
T. Pawlik, R. Hruban, C. Wolfgang and M. Weiss
The Johns Hopkins Hospital, Baltimore, MD
Background: Groove pancreatitis (GP) is a rare condition
that occurs in the groove region between the head of pan-
creas, the duodenum and the common bile duct (CBD) The
diagnostic features and best treatment remain unknown. Our
goal was to identify clinical features that may differentiate
GP from malignancy and evaluate long-term outcomes of
pancreaticoduodenectomy (PD) for GP.
Methods: We reviewed all patients who underwent PD at
our institution from 2005–2013 and identified those with GP
on pathology. The demographic features, diagnostic findings,
surgical complications and long-term outcomes were
characterized.
Results: Among 1424 patients who underwent PD, 14 (1%)
were diagnosed with GP on pathology. The majority (71%)
were male. Six (43%) abused alcohol, 4 (29%) tobacco and 3
(21%) both. The most common symptoms were abdominal
pain (64%), decreased appetite (50%), and weight loss
(50%). Nine (64%) patients had a clinical history or radio-
logical features of pancreatitis upon presentation. Imaging
demonstrated a cystic pancreatic head mass in 8 (57%), focal
enlargement of the pancreatic duct and CBD in 8 (57%) and
5 (36%), respectively. The overall complication rate was
57.1% including two (14.3%) 30-day mortalities. At a
median follow-up of 14.2 months, the remaining patients are
asymptomatic and without radiologic evidence of recurrence.
Conclusion: GP is a rare pathologic finding. We identified
no reliable pre-operative features to distinguish GP from
malignancy. In the light of the uncertain diagnosis, sympto-
matic presentation, and inability to reliably distinguish GP
from pancreatic cancer, we consider PD to be an acceptable
treatment of GP.
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OP-II.33 PERIOPERATIVE MORBIDITY
AND MORTALITY AFTER
PANCREATECTOMY: A SYSTEMATIC
REVIEW OF PREDICTION SCORES,
MODELS AND NOMOGRAMS
J. Aubin1, R. Lapointe2, F. Vandenbroucke-Menu2 and
G. Martel1
1Liver And Pancreas Unit, Division Of General Surgery,
The Ottawa Hospital, University Of Ottawa, Ottawa, ON;
2HPB Surgery And Liver Transplantation Unit, Hal
Saint-Luc, CHUM, Montreal, QC
Pancreatic resection is associated with a high rate of postop-
erative morbidity and mortality. Numerous scoring systems
and predictive models have been developed to forecast the
postoperative course of individual patients. A systematic
review of the literature pertaining to perioperative morbidity
and mortality risk prediction scores after pancreatic resection
was carried out. A review protocol was utilized. Papers pre-
senting or utilizing prediction scores, models and nomo-
grams were retrieved. The characteristics of each score were
reviewed, as were their validation history. 788 de-duplicated
studies were screened. 58 studies fit the criteria for inclusion,
yielding 44 different scores or prognostic models. Among
these scores, 54.5% of papers presented novel scores that
were not further evaluated or utlized in the literature. 45.5%
of scores were pre-existing and being validated for or applied
to pancreatectomy, such that, notably, POSSUM was pre-
sented in 32.8% of papers, and P-POSSUM and E-PASS in
6.9% of papers, each. Identified scores predicted several dif-
ferent types of outcomes, including mortality, overall mor-
bidity, and specific morbidity such as pancreatic fistulas and
post-operative diabetes. 38.6% of scores are validated for
pancreatectomy; 30% of pre-established scores and 45.8% of
novel scores. This work identified 44 different scores to
predict post-operative morbidity and mortality after pancrea-
tectomy. Many scores were generic, while others pertained to
specific populations or outcomes. The overall degree of vali-
dation was poor. Further prospective studies are needed to
validate the remaining scores. The usefulness of individual
scores and their ability to predict an outcome of interest was
highly variable.
OP-II.34 THE IMPACT OF ABERRANT
ANATOMY OF THE HEPATIC ARTERY
ON RESECTION MARGIN STATUS IN
PANCREATICODUODENECTOMY
P. Casey, R. De Souza, S. Lapsia, Z. Ali, K. Elhadd,
A. Kausar, D. Chang, A. Krige, J. Thomas and D. Subar
Department Of Hepatopancreatobiliary Surgery,
Blackburn, LANCASHIRE
Several studies have demonstrated that resection status (R)
affects survival after resection of pancreatic adenocarcinoma.
This study aims to assess the association between the pres-
ence of abnormal arterial anatomy (namely, a replaced or
aberrant right hepatic artery) and resection margin status.
Between 2007 and 2012 we analysed the pathology and
pre-operative cross sectional images of all patients undergo-
ing Pancreaticoduodenectomy for pancreatic adenocarci-
noma. Aberrant arterial anatomy was classified by a single
Radiologist as per Michels classification. Statistical analysis
was conducted using SpSS (IBM) statistical program. One-
hundred and fourty eight (148) pancreaticoduodenectomies
were performed of which 75 were for adenocarcinoma of the
head of the pancreas. The male to female ratio was 45 : 30
with a mean age of 65. Fifty-nine patients had a positive
resection margins with 16 having clear margins. The medial
(SMV) margin was the most commonly involved. Fifteen
patients (21%) had aberrant arterial anatomy of the hepatic
artery course. The presence of aberrant arterial anatomy did
not have a statistically significant impact on the R Status
(p = 0.67), involvement of the medial (p = 0.34), or
Transection margin (p = 0.22). In concordance with other
studies, R status correlated with overall survival (p = 0.02)
suggesting that the presence of arterial variation does not
affect survival in adenocarcinoma of the pancreas. There
appears to be no increased risk of a positive resection margin
in pancreaticoduodenectomy in the presence of variant arte-
rial anatomy of the right hepatic artery. Identification of
vascular anomalies by pre-operative imaging will reduce the
risk of intraoperative injury.
OP-II.35 DIFFERENCES IN OUTCOMES
IN PANCREATICODUODENECTOMY (PD)
IN THE MODERN ERA: DOES A
MALIGNANT DIAGNOSIS MAKE A
DIFFERENCE?
S. Cheek, S. Patel, H. Osman and D. Jeyarajah
Methodist Dallas Medical Center, Dallas, TX
Objective: Historically, there has been less enthusiasm for
doing PD for benign conditions than malignant disease
because of high morbidity and mortality rates. With
improved outcomes PD is more commonly being preformed
for benign indication, including pancreatitis and premalig-
nant lesions. The aim of this study is to evaluate the number
of PD done for benign disease and the differences in out-
comes between pancreatic resection for malignant versus
benign disease.
Method: 321 patients who underwent PD between Septem-
ber 2005-May 2013 were identified retrospectively from our
database. Diagnoses were divided into malignant and benign
conditions. Malignant conditions include adenocarcinoma,
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neuroendocrine tumors, and metastatic disease. IPMN, pan-
creatitis, and adenoma constitute 75% of benign condition.
Cases were analyzed for operative time, operative blood loss,
length of stay (LOS) and complication.
Results: 226 (70%) had malignant disease (group A) and 95
(30%) patients had benign disease (group B). There was no
statistically significant difference in median operative time,
blood loss, and length of stay (LOS) between malignant and
benign group.
Conclusion: Operative time, blood loss, and LOS, were not
statistically significant between the two groups. PD can be
performed at a tertiary referral center for patients with both
benign and malignant conditions with excellent and compa-
rable outcomes.
OP-II.36 THE BENEFITS OF
LAPAROSCOPIC PANCREATECTOMY: IT
DOES MAKE A DIFFERENCE
S. Cheek, S. Patel, H. Osman and D. Jeyarajah
Methodist Dallas Medical Center, Dallas , TX
Objective: Laparoscopic approach for distal pancreatecomy
has been increasing recently. The aim of this study is
to evaluate the operative and oncologic measures of
laparoscopic distal pancreatectomy (DP) at a non-university
setting.
Methods: 169 patients who underwent a distal pancreatec-
tomy at our tertiary referral center from September 2005-
May 2013 were identified from an institutional database.
These cases were evaluated based on method of resection,
pathologic diagnosis, intraoperative blood loss, OR time, and
LOS. In malignant cases, margin of resection weas evaluated.
Results: A total of 169 distal pancreatectomies were per-
formed. An open resection (group A) was done 56.8% (96) of
the time and a laparoscopic resection (Group B) was done
43.2% (73). Group B had statistically significant less opera-
tive blood loss and shorter length of stay. There was a higher
rate of negative margins in patients with malignant diagnosis
in group B (p < 0.0001). (Table 1)
Conclusion: This study demonstrates that LDP can result in
decreased blood loss and LOS compared to open resection.
Moreover, in carefully selected patients, excellent oncologic
parameters can be achieved.
OP-II.37 LONG-TERM SURVIVAL AFTER
RESECTION OF PANCREATIC CANCER:
SIGNIFICANCE OF EARLY DETECTION
AND HISTOLOGICALLY CURATIVE
RESECTION
T. Yamamoto, H. Kinoshita, Y. Sakamoto, K. Okada,
K. Inoguchi, S. Yao, S. Kaihara, R. Hosotani and S. Yagi
Kobe City Medical Center General Hospital, Kobe,
HYOGO
Background: The prognosis of patients with pancreatic
cancer remains poor. The number of long-term survivors,
however, has been increasing. In this study, we retrospec-
tively analyzed patients with pancreatic cancer who received
pancreatic resection and assessed the factors that affected
long-term survival and the clinicopathological characteristics
of long-term survivors.
Methods: From January 2000 to December 2011, 195
patients underwent pancreatic resection in our hospital. We
first analyzed the prognostic factors of pancreatic cancer
after pancreatic resection in these patients, of whom 96
patients were observed for more than 5 years. We analyzed
the clinicopathological characteristics of patients who sur-
vived for 5 years or more and compared them to those of the
patients who died within 5 years.
Results: Using multivariate analysis, tumor size ≤ 20 mm
(hazard ratio [HR] 0.38; confidence interval [CI] 0.16–0.76)
and negative surgical margin (R0 resection) (HR 0.46; CI
0.29–0.73) were independent favorable prognostic factors.
Comparison of 5-year survivors (n = 20) to non-survivors
(n = 76) revealed that lower levels of pancreatic cancer-
associated antigen (DUPAN-2) (1318 ± 4706 vs.
1655 ± 4210), tumor size ≤ 20 mm (35% vs. 8%), R0 resec-
tion (95% vs. 61%), and no lymph node metastases (60% vs.
18%), were significantly associated with 5-year survival.
Conclusions: Negative surgical margin and tumor size
≤20 mm were independent favorable prognostic factors. His-
tologically curative resection and early tumor detection are
important in treating pancreatic cancer and achieving long-
term survival.
OP-II.38 SOCIOECONOMIC STATUS AND
SURGICAL OUTCOMES AFTER TOTAL
PANCREATECTOMY
H. Schmidt, E. M. Kilbane, A. P. Turner, M. G. House,
N. J. Zyromski, A. Nakeeb, C. M. Schmidt and E. P. Ceppa
Indiana University School Of Medicine, Indianapolis, IN
Background: A paucity of data exists between socioeco-
nomic status (SES) and surgical outcomes. Patients deemed
“poor” are presumed to suffer from higher rates of postop-
erative morbidity. The aim of this study was to determine if
the level of Median Household Income (MHI) correlated
with increased morbidity following total pancreatectomy
(TP).
Methods: Consecutive cases of TP (n = 21) were reviewed
at a single high-volume institution between 2008 and 2012.
Annual MHI was derived from the patient’s zip code as
determined by U.S. Census data; patients groups were
divided by high or low SES being above or below $50 K. All
cases were monitored with complete 30-day outcomes
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through the American College of Surgeons-National Surgical
Quality Improvement Program. Electronic medical records
were used for 90-day outcomes. Two-way statistical analyses
were performed between the patient categories.
Results: The high SES group (n = 10) as compared to the
low SES group (n = 11) had a significantly higher MHI
(p < 0.001). No significant differences existed in preopera-
tive risk, intraoperative variables, surgical pathology, nor in
either 30-day and 90-day readmissions or mortality. The
lower SES group had a higher rate of total postoperative
morbidity at 30-day (p < 0.01); no difference was seen at
90-day morbidity (p = 0.09).
Conclusion: Low SES imparts a higher short-term morbid-
ity to patients undergoing TP, although the long-term disad-
vantage is not evident. This may suggest that lower SES is
not a reliable criterion when assessing surgical risk for this
patient population. Further study of this topic is warranted
with a larger patient sample and for regional pancreatectomy.
OP-II.39 OUTCOMES IN OPEN VERSUS
LAPAROSCOPIC DISTAL
PANCREATECTOMY
R. Pieretti- Vanmarcke1,3, J. Wargo1,3, C. Fernandez-Del
Castillo1,3, H. Zheng2,3, A. Merrill1,3, S. Thayer1,3,
K. Lillemoe1,3 and C. R. Ferrone1,3
1Department Of Surgery, Massachusetts General Hospital,
Boston, MA; 2Department Of Biostatistics, Massachusetts
General Hospital, Boston, MA; 3Harvard Medical School,
Boston, MA
Objective: To compare the outcomes of patients undergoing
either open (ODP) or laparoscopic (LDP) resection of the
distal pancreas.
Methods: A single institution retrospective analysis of 429
patients undergoing distal pancreatectomies performed
between 1/2004–12/2012. Demographics, tumor characteris-
tics, operative technique and long-term outcomes were
examined.
Results: A total of 429 patients underwent distal pancreate-
ctomy of whom 43% were male with a median age of 60.
Patients underwent LDP (n = 104) or ODP (n = 325). 18
patients (17%) were converted to an open procedure. Opera-
tive time was significantly longer for LDP than ODP
(p = 0.0016). The most common pathologic diagnoses were
neuroendocrine tumor (21%), ductal adenocarcinoma (18%),
mucinous cystic neoplasm/adenoma (9%) and intraductal
papillary mucinous tumor (8%). Median tumor diameter was
3.1 cm and 3.0 cm, respectively. BMI was significantly
higher in patients who underwent LDP than ODP
(p = 0.0048). Length of stay was longer in patients who had
an ODP (5.5 days, stdev = 2.81 vs 6.98 days, stdev = 5.61)
(p = 0.0003). Total number of complications was also higher
in patients who had an ODP (p = 0.016). Positive margins
were higher in ODP (p = 0.05).
Conclusion: In the era of cost containment laparoscopic
distal pancreatectomy is a safe operation which offers a
shorter LOS and lower morbidity than ODP, despite a longer
operative time.
OP-II.40 OUTCOME AFTER REVISION
OF THE PANCREATICOJEJUNOSTOMY:
A SINGLE INSTITUTION EXPERIENCE
A. I. Gagnon, R. Birkett and T. Schnelldorfer
Lahey Clinic, Burlington, MA
Introduction: Long-term complications derived from the
pancreatic anastomosis after pancreatoduodenectomy are
fortunately infrequent. When this type of complication
occurs operative revision is commonly needed, which can
represent a significant challenge to the surgeon.
Methods: The records of all patients who underwent a pan-
creatic operation at our institution between 2003 and 2012
were retrospectively reviewed and analyzed.
Results: Three patients originally underwent pancreatoduo-
denectomy with a final diagnosis of inflammatory mass in
two and IPMN with low grade dysplasia in one. The median
age was 49 years. The indication for operation was
anastomotic stricture in one and chronic pancreati-
cocutaneous fistula in two. Two were revised to
pancreaticogastrostomy and one underwent revision to
pancreaticojejunostomy. Peri-operative morbidity occurred
in one patient without any mortality. Median estimated
operative blood loss was 250 mL. There were no reports of
major vascular injury, such as portal vein injury, during the
operation. Median length of hospital stay was 7 days (range
5 to 9 days). Median follow-up was 1 year (range 0 to 4
years). At last follow-up, all patients had complete clinical
resolution of their symptoms without any evidence of pan-
creatic duct obstruction.
Conclusion: Revision to pancreaticojejunostomy seems
preferable, but revision to pancreaticogastrostomy should be
considered for patients at risk for ductal strictures from
chronic pancreatitis, thus allowing endoscopic access.
Operative revision of the pancreatic anastomosis, while tech-
nically challenging, is overall tolerated well. The operation
can be performed with minimal blood loss, low peri-
operative morbidity, and long lasting patency of the anasto-
mosis in suitably selected patients.
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OP-II.41 INCREASING INSTITUTIONAL
EXPERIENCE AND EXPERTISE
IMPROVES DIAGNOSTIC YIELD OF
ENDOSCOPIC ULTRASOUND (EUS) IN
SOLID PANCREATIC TUMORS
S. D. Kachare1,2, A. G. Kaul1, T. L. Fitzgerald1,2,3 and
E. E. Zervos1,2,3
1East Carolina University, Brody School Of Medicine,
Greenville, NORTH CAROLINA; 2Vidant Medical Center,
Greenville, NORTH CAROLINA; 3Leo W. Jenkins Cancer
Center, Greenville, NORTH CAROLINA
Background: The diagnostic yield of EUS is multifactorial
including: the endoscopist’s /cytopathologist’s expertise and
underlying patient and tumor characteristics. The purpose of
this study was to determine the diagnostic yield of repeat
attempts at EUS for solid pancreatic neoplasms while con-
trolling for patient and tumor factors.
Methods: A prospective database of patients undergoing
repeat EUS for solid pancreatic neoplasms was queried to
determine its impact on clinical course decision making. All
secondary EUS were performed and interpreted at a high
volume center whereas initial EUS occurred early in our
institution’s learning curve. Subjective impressions and
pathology were compared to surgical pathology or clinical
course to determine the utility of repeat EUS.
Results: Ten patients underwent second and third (n = 3)
attempts to achieve diagnosis. Final EUS yielded a
pathologic diagnosis or impression that changed clinical
course in 4 patients. One diagnosed subjectively with
pseudopapillary tumor continues to be followed, one had
adenocarcinoma confirmed on surgical pathology and two
diagnosed with adenocarcinoma were ultimately proven to
have PanIN and benign disease. The final six patients had
inconclusive findings on repeat EUS, four of whom under-
went successful percutaneous or open biopsies while the final
two remain undiagnosed due to refusal of further diagnostic
measures.
Conclusion: Repeat EUS in experienced hands changes
clinical decision making 40 % of the time. Final pathology,
however, was discordant from EUS pathology in half of these
cases. While the yield is low, referral for salvage EUS in this
study justified resection or continued surveillance in highly
select patients.
OP-II.43 10 STEPS TO SALVATION –
CONTROLLING AN IVC BLEED DURING
MAJOR HEPATECTOMY
J. B. Conneely1 and S. Jayaraman1,2
1University Of Toronto, Toronto, ONTARIO; 2HPB Surgery
Service, St. Joseph’s Health Centre, Toronto, ONTARIO
This vignette describes an approach to controlling major
hemorrhage encountered during a total-laparoscopic right
hepatectomy for metastatic breast cancer. A major reason for
surgeons’ reluctance to embrace laparoscopic major hepate-
ctomy, is the concern about how to deal with significant
intra-operative hemorrhage. In particular, bleeding from the
Hepatic veins or inferior vena cava (IVC) is especially
ominous, however, certain fundamental surgical principles
for safety hold true regardless of the approach. These funda-
mental principles are as follows: maintaining control of the
bleeding site; improving access to the surgical field; and
increasing operative space. We describe herein, our approach
to controlling and resolving a major bleed from the Right
Hepatic Vein – IVC confluence encountered in the final
stages of parenchymal division during a formal right hepate-
ctomy. Specifically, we document 10 Steps we took to ensure
safe, timely control of a major bleed without compromizing
patient safety or oncologic outcome, or having to resort to
urgent conversion to open surgery. We propose that these
steps can safely be applied to similar intra-operative
scenarios.
OP-II.44 SAFE AND EASY PRINGLE FOR
LAPAROSCOPIC LIVER RESECTION
M. M. Dua1, D. J. Worhunsky1, K. J. Hwa2, B. Siu1,
G. A. Poultsides1, J. A. Norton1 and B. C. Visser1
1Stanford University School Of Medicine, Stanford, CA;
2VA Palo Alto Health Care System, Palo Alto, CA
Introduction: A primary concern during laparoscopic liver
resection (LapLR) is bleeding during parenchymal
transection. Intermittent vascular occlusion minimizes blood
loss; however, is challenging to reproduce during laparos-
copy. Described techniques are difficult to achieve
emergently or are incompletely occlusive. This study
describes the safety and efficacy of a facile method for
Pringle maneuver during LapLR.
Methods: 145 consecutive patients who underwent LapLR
from 2007–2013 were retrospectively reviewed. For
Pringle, a laparoscopic articulating esophageal-dissector is
used to encircle the hepatoduodenal ligament with an
umbilical tape. The tape is externalized through an 12-F
flexible Rumel tourniquet which runs parallel to and along-
side a port used for the operation. The internal end of the
catheter is close to the pedicle and the external end is extra-
corporeal, allowing for easy pringle (Figure A). Pringle
maneuver (PM, n = 82) was compared to “no occlusion”
(NO, n = 63) for intraoperative characteristics and postop-
erative complications.
Results: Annual application of the tourniquet and use of
Pringle increased from 27% to 80% (p = 0.002) and 20% to
60% (p = 0.04), respectively. Median (IQR) occlusion time
was 23 minutes (15–34). There was no morbidity associated
Abstracts 73
© 2014 The Authors
HPB © 2014 Americas Hepato-Pancreato-Biliary AssociationHPB 2014, 16 (Suppl. 1), 1–99
with placement of the tourniquet. Although operative time
and EBL were higher in PM, there were no significant dif-
ferences noted in transfusion or liver function postopera-
tively (Table 1). There were only two conversions to open
surgery.
Conclusion: Extracorporeal tourniquet placement in LapLR
is a quick and safe method of gaining control for inflow
occlusion. Routine adoption of laparoscopic Pringle facili-
tates low conversion rates and increased safety.
OP-II.45 TRICKS OF THE TRADE:
OPERATIVE MANAGEMENT OF PORTAL
ANNULAR PANCREAS IN PATIENTS
UNDERGOING
PANCREATICODUODENECTOMY
A. V. Maker and V. K. Maker
University Of Illinois At Chicago, Chicago, IL
Background: Portal annular pancreas (PAP) is an asympto-
matic and under-recognized congenital anomaly present in ∼
2% of the population. It is characterized by pancreatic
encasement of the portal vein (PV) where the uncinate fuses
to the dorsal surface of the body. It is critical to recognize this
anomaly before pancreaticoduodenectomy to appropriately
manage the pancreatic anastomosis, minimize post-operative
fistula/complications, and to provide an appropriate
oncologic resection. Description of the technique: The pan-
creas encircles the main PV superior to the splenic conflu-
ence and the main pancreatic duct bifurcates at the level of
the SMA circumscribing the portal vein (Jones modified type
II). It is critical to trace the ductal anatomy to determine the
appropriate location to divide the pancreas in order to avoid
a retroportal anastomosis. Intraoperative ultrasound tracing
the ducts is employed and demonstrated. Operative video
demonstrates the pancreas encircling the PV (see figure),
division of the neck of the pancreas, identification of the
ventral duct for an anterior pancreatico-jejunostomy, fol-
lowed by division of the retroportal pancreas at the level of
the SMA, and closure of the dorsal duct. Wide tumor margins
are obtained.
Conclusion: It is important to be familiar with the anatomy
of the PAP in order to recognize this anomaly and avoid
technical problems at the time of resection. This video, asso-
ciated illustrations, and intraoperative photos demonstrate
the critical components of the anomaly and illustrate a useful
technique to manage tumors requiring pancreaticoduo-
denectomy in the setting of PAP.
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OP-II.46 TRANCYSTIC BILIARY
DESCOMPRESSION WITH
INTERNAL-EXTERNAL BILIARY
DRAINAGE PLACED
LAPAROSCOPICALLY AFTER BILE
DUCT EXPLORATION. PRELIMINARY
REPORT OF AN INNOVATIVE
TECHNIQUE
G. E. Pfaffen, P. Barros Schelotto, P. Romero and
G. E. Gondolesi
Fundacion Favaloro, Buenos Aires, BUENOS AIRES
It is part of a good HPB surgical practice to assure an adequate
biliary drainage into the duodenum after any laparoscopic
common bile duct exploration (LCBDE). Often early after
LCBDE, edema or spasm are responsable of the initial Spinchter
of Oddi dysfunction (SOD). Pharmacological, endoscopic or
surgical procedures have been reported to resolve this event. The
aim of this report is to present our preliminary results of three
consecutive patients with poor biliary drainage secondary to
SOD treated by placement of a Laparoscopic Trancystic
Transpapillary Internal-External Biliary Drainage (LTTIEBD).
We report 3 patients operated between june 2011 – april 2013,
who underwent LCBDE for common bile duct (CBD) stones.
Once choledochal lithiasis was removed, the intraoperative
cholangiogram (IOC) showed absence or delay empty into the
duodenum in all of them. In two patients a LTTIEBD was per-
formed and the postoperative was uneventful. In the 3nd patient,
abdominal pain and secondary bile leak through the primary
choledochorraphy was diagnosed early after bile duct explora-
tion. Consequently, we reoperated this patient removing the liga-
ture of the cystic stump and a LTTIEBD was used, the patient
was discharged 48 hours later. The LTTIEBD was removed in all
patient 45 days after placement without complications. During a
median follow-up period of 12 months (4–25) no clinical or
laboratory abnormalities were observed. The excellent outcome
of these patients demonstrates that LTTIEBD could be a useful
tool for the management SOD after LCBDE. A larger cohort is
needed to validate these results.
OP-II.48 INTRAHEPATIC
CHOLANGIOJEJUNOSTOMY FOR THE
TREATMENT OF COMPLEX BILIARY
STENOSIS AFTER PEDIATRIC
LIVING-DONOR LIVER
TRANSPLANTATION
R. Sanchez Clariá, F. A. Alvarez, N. Resio,
E. De Santibañes and M. Ciardullo
General Surgery And Liver Transplant Unit, Hospital
Italiano De Buenos Aires., Ciudad Autonoma De Buenos
Aires, BUENOS AIRES
Background: The treatment of complex biliary stenosis
after pediatric living-donor liver transplantation (LDLT) is
challenging, especially when there is an intrahepatic stenosis
of the hepaticojejunostomy. Intrahepatic cholangiojejunos-
tomy (IHCJ) has been classically applied for the treatment of
malignant disease. We describe an innovative technique of
IHCJ for the treatment of complex biliary stenosis after
pediatric LDLT.
Technique: The first step is to replace a previous percuta-
neous biliary drainage, usually from an 8 fr catheter to a 12 fr
catheter. Once the drain tract is consolidated (3–4 weeks) and
a patent hepatic artery has been certified by angiography, the
surgery is carried out. During surgery, the previous anasto-
mosis is revised to confirm the absence of extrahepatic bile
ducts. The drain is removed and a flexible metal stylet is
introduced trough the tract into the bile ducts. Subsequently,
the most superficial aspect of the biliary tree is recognized by
palpation of the round tip of the stylet in the liver surface.
The liver parenchyma is then transected until the bile duct is
reached and opened longitudinally (Figure). A side-to-side
anastomosis to the previous Roux-en-Y limb is performed
using a 6–0 polypropylene suture in an interrupted fashion
over a silicone stent. Three pediatric recipients were success-
fully treated with this approach.
Conclusion: The presented technique of IHCJ was feasible
and safe in experienced hands. This novel approach allows
treating cholestasis in pediatric LDLT recipients with a
lack of extrahepatic ducts due to complex biliary stenosis
that failed percutaneous treatment, thus avoiding liver
retransplantation.
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OP-II.49 ULTRASOUND-GUIDED
INTRAOPERATIVE TRANSDUODENAL
PANCREATIC HEAD BIOPSY A SAFE
AND EFFECTIVE PROCEDURE TO
EXCLUDE MALIGNANCY FOR
OBSTRUCTIVE JAUNDICE PATIENTS:
TECHNICAL NOTE
N. Ikoma, T. Karahashi and Y. Hosoda
Department Of Surgery, Saitama Social Insurance
Hospital, Kitaurawa, SAITAMA
Background: Despite advanced imaging and endoscopic
technologies, differentiating between chronic pancreatitis
and pancreatic adenocarcinoma is challenging. At times
patients undergo “blind” pancreatic resections without histo-
logical confirmation of diagnosis, and consequently bear the
significant risk associated with pancreatic surgery for benign
disease.
Methods: Ultrasound-guided intraoperative transduodenal
pancreatic head biopsy was performed for a patient with a
pancreatic head tumor with obstructive jaundice, who had
equivocal findings on pre-operative evaluation with imaging
studies and ERCP, between pancreatic cancer and tumor-
forming pancreatitis.
Results: Frozen section was negative for malignancy and
choledocoduodenostomy was performed without complica-
tion. The patient has been in good condition with resolution
of obstructive jaundice at 24 months follow-up.
Conclusion: Ultrasound-guided intraoperative transduo-
denal pancreatic head tumor biopsy is an alternative strategy
to establish an accurate diagnosis before proceeding with
extensive pancreatic surgery. This procedure suits the patient
with a pancreatic head tumor and obstructive jaundice who
requires a biliary drainage procedure.
OP-II.50 CONCEPT OF THE
MESOPANCREAS: COINING A NEW
SURGICAL ANATOMICAL SPACE
S. Patel, S. Cheek, H. Osman and D. Jeyarajah
Methodist Dallas, Dallas, TX
Background: The concept of the mesorectum has become
well accepted. It represents a known space of oncological
relevance. In the same light, we believe that the
mesopancreas represents essentially an anatomical space
with similar anatomical rationale as the mesorectum. The
mesopancreas we describe as extending from the posterior
aspect of the pancreatic head to behind the mesenteric
vessels. It contains lymphatics, nerve plexus, adipose tissue
and vascular structures. This concept of the mesopancreas
has not been anatomically classified in the surgical literature,
though there have been few studies describing the concept.
Techniques: After initial exploration, the duodenum is
kocherized with a generous Cattell-Brasch maneuver. After divi-
sion of the pancreatic neck, the proximal jejunum is also divided
and passed to the right side underneath the superior mesenteric
artery (SMA). The specimen is then retracted anteriorly and
medially and the mesopancreas is visualized. The mesopancreas
is incised along the SMA heading towards the portal vein in an
SMA first approach. The mesopancreas is taken down with the
electrocautery bovie on a right angle clamp. In this manner, all
tissue in the retropancreatic space and in the interface between
SMAand portal vein is included in the specimen. We believe this
is an important step into achieving R0 resection which can trans-
late into prolong survival.
OP-II.51 FACTORS PREDICTIVE OF
CHOLEDOCHOLITHIASIS. OPTIMIZING
MANAGEMENT STRATEGIES
C. Rengifo, D. Chang, R. Watson, A. Kausar and D. Subar
Department Of HPB Surgery, Blackburn, LANCASHIRE
Background: The investigation and management of patients
with potential bile duct stones vary between institutions and
depends on resources.
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Aim: The aim of this study is to develop a risk stratification
process for determining the presence of choledocholithiasis
in patients with gallstones who do not demonstrate common
bile duct stones(CBDS) on ultrasound or have gallstone pan-
creatitis or cholangitis.
Methods: This is a retrospective study of all patients pre-
senting to our institution from March 2011-December 2012
for symptomatic gallstones who had MRCP or ERCP. Risk
factors including age, sex, dilation of common bile
duct(>7 mm), elevated alanine transaminase(ALT), elevated
alkaline phosphatase(ALP) and elevated bilirubin were ana-
lysed for predictive significance for the presence of common
bile duct stones based on MRCP/ERCP results. Each risk
factor was then scored as 0 or 1 based on cut-off value. The
cumulative scores were compared to the presence of bile duct
stones on ERCP/MRCP.
Results: On univariate analysis, age, dilated common bile
duct on US(>7 mm), ALP >200 IU/L, ALT >53 IU/L and
bilirubin >22 μmol/L were all statistically significant. The
positive predictive rate for individual factors ranged from
53.3%-43.5%. A cumulative score of 5 was 100% predictive
for CBDS. Scores of between 4- 1 had a predictive probabil-
ity of between 52.9% and 20%. Patients scoring a zero had
no bile duct stones.
Conclusion: Patients scoring a 5 on identified risk factors
for CBDS should go straight to ERCP. Patients scoring 4-1
should be considered for MRCP. Patients scoring zero should
be considered for laparoscopic cholecystectomy without
preoperative MRCP/ERCP.
OP-II.53 COMPLICATIONS AFTER
SURGICAL REPAIR OF BILE DUCT
INJURY
D. Zamora-Valdés, M. Vilatoba, A. G. Contreras,
I. Dominguez-Rosado, A. L. Carrete, M. Gonzalez,
C. Kaufmann, E. M. Saucedo, S. Mier and M. A. Mercado
INCMNSZ, Mexico City, DF
Background & aim: The surveillance of surgical complica-
tions may lead to improvement in medical care. The aim of
this paper is to study the incidence and risk factors for sur-
gical complications in patients undergoing bile duct injury
(BDI) surgical repair.
Methods: We review our prospective database of patients
with BDI undergoung surgical repair from January 2003 to
December 2011. Surgical complications were graded accord-
ing to the Clavien-Dindo (CD) and Accordion systems. Com-
prehensive Complication Index (CCI) was calculated.
Complication rate was compared with two other series in the
literature. Multivariate analysis was performed to evaluate
risk factors associated with major morbility.
Results: Surgical repair was performed in 425 patients;
Roux-en-Y hepaticojejunostomy (HJ) in 299 patients;
neoconfluence in 101 patients (23.8%), portoenterostomy in
25 patients (5.9%) and double barrel HJ in 2 patients (0.5%);
202 patients (47.5%) had complications. Major morbidity
occurred in 17.4% of patients. According to CD, postopera-
tive complications were: I 4%, II 26.1%, IIIa 4.2%, IIIb
3.1%, IVa 4.5%, IVb 4.0% and V 1.6%. According to Accor-
dion classification, postoperative complications were: I 4%,
II 26.1%, III 4.5%, IV 3.1%, V 8.2% and VI 1.6%. Mean CCI
was 15.52 ± 19.36. Risk factors associated with major
morbility were age, preoperative serum albumin, preopera-
tive pericholangitic abscesses, ASA classification, operative
time (hours) and repair other than HJ.
Conclusion: Morbidity associated with surgical repair of
BDI is noteworthy. Directed strategies should be planned to
reduce it. Main factors associated with major morbidity are
patient status and complexity of bile duct lesion.
OP-II.54 COMPLICATIONS OF
PERCUTANEOUS CHOLECYSTOSTOMY
TUBE (PC) IN THE TREATMENT OF
ACUTE CHOLECYSTITIS (AC)
A. D. Guerron, A. Abdel Azim, M. Moorman,
G. McLennan and M. Loor
Cleveland Clinic Foundation, Cleveland, OH
Introduction: Acute cholecystitis (AC) is a common surgi-
cal emergency, often affecting patients with serious medical
comorbidities. Procedure related complications and patients
risks have not been correlated with outcome. As an initial
step in the development of an evidence based care path for
AC, we review our series of patients treated with PC.
Methods: An IRB approved, retrospective analysis of a pro-
spectively maintained database was conducted.
Results: A total of 345 patient underwent PC between 2003
and 2012 were included in the analysis. Males comprised
57% and females 42%. Periprocedural complications
occurred in 20% of patients, the most prevalent of which was
dislodgement in 36%, followed by bleeding and occlusion (8
and 6%). These were typically handled with tube replace-
ment. In patients who experienced a tube-related complica-
tion, mortality was 52%, compared to 44% in the no
complication group. A total of 83 patients (27.8%) eventually
underwent cholecystectomy at a median of 99 days post PC.
Complications presented at a median of 83 days post PC.
Patients with tube related complications were less likely to
ultimately have a cholecystectomy.
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Conclusion: In this study, we identified the rates of compli-
cations associated with PC. Cholecystostomy dislodgement
or dysfunction are common and predict patient outcome. A
minority of patients ultimately underwent cholecystectomy.
Further studies regarding timing of these complications are
required. This information is useful in guiding the manage-
ment of patients with severe acute cholecystitis.
OP-II.55 PREDICTING (AVOIDING)
INCIDENTAL GALLBLADDER CANCER
K. Patel, A. Sautter, T. Buddensick, B. Wu, H. Ferdosi,
D. Narducci, M. Siddique, L. Setiawan, H. Shaukat,
G. Sulkowski, S. O. Farooqui, G. C. Kowdley and
S. C. Cunningham
Saint Agnes Hospital And Cancer Institute, Catonsville, MD
Introduction: Incidental gallbladder cancer (IGBCa) is an
uncommon finding following cholecystectomy. Conse-
quences of discovering IGBCa postoperatively include need
for repeat operation and worse median survival if bile spill-
age was allowed to occur, both of which could be avoided if
IGBCa were suspected preoperatively. We hypothesized that
criteria may exist to increase the chance of predicting
IGBCa.
Methods: Retrospective single-institution review identified
patients with IGBCa. Precholecystectomy ultrasound (US)
images for both IGBCa cases and matched controls were
re-reviewed by a blinded radiologist. Statistical analysis was
done using chi-square test and t-test. Differences were con-
sidered significant(*) when p < 0.05.
Results: Among 5770 cholecystectomies performed 2000–
2011, there were 22 (0.38%) IGBCa cases. Patients with
IGBCa were older (72 vs 52),* but similar regarding gender
and race. Conversion to open cholecystectomy was more
common with IGBCa (18% vs 3.5%).* Preoperative imaging
tests, including CT and ERCP were more commonly per-
formed with IGBCa.* CBD diameter was higher in IGBCa
cases (7.2 mm vs 5.0 mm).* Alkaline phosphatase, bilirubin,
and prothrombin time were all significantly higher, and
albumin lower, in IGBCa cases.* On blinded review of US
imaging, gallbladder wall thickening (GBWT), but not
pericholecystic fluid (PCCF) or gallstones, was significantly
more common in IGBCa cases (70.0% vs 21.3%)* and mean
GBWT was significantly greater in IGBCa cases (7.5 mm vs
3.8 mm).*
Conclusion: Advanced age, elevated alkaline phosphatase,
bilirubin, and prothrombin time, the existence of multiple
preoperative imaging tests, and isolated GBWT without
other signs of cholecystitis (eg, PCCF and gallstones) are risk
factors that may raise suspicion for IGBCa.
OP-II.56 SHORT TERM PHYSIOLOGICAL
EFFECTS OF A
HEPATOPANCREATICOBILIARY
RESERVOIR
A. Yusuf2 and B. Asiyanbola1
1University Of Maryland, Easton Memorial, Easton, MD;
2Johns Hopkins Center For Talented Youth, Baltimore, MD
Introduction: Recent reports of the surgical placement of
hepatopancreatobiliary (HPB) reservoirs have been pub-
lished. Such reservoirs are potentially of use in targeted or
regional management because unlike systemic therapy, tar-
geting or regionalizing appears to be more efficient and less
costly. Reservoirs have been used to manage HPB malignan-
cies and diabetes. However, there are scant reports of the
physiologic effect of creating reservoirs. The objective is to
investigate what short term physiologic changes occur with
creation of a gallbladder reservoir.
Methods: Approval from the Animal Care and Use Com-
mittee was obtained. Five female swine including two con-
trols and three test subjects were used. Gallbladder reservoirs
whose walls were cystic mucosa and serosa containing
flurescent nanomicelles were created, while controls had
incision of the gallbladder. Drainage was through the cystic
then portal veins into liver. Serum samples were taken for
liver function tests (LFT’s) and inflammatory markers (IF) at
0, 12, 24, and 36 hours. Ultrasound was carried out at 12 and
24 hours. Euthanasia was at 36 hours and samples sent for
histology.
Results: Similar to the swine that acted as controls, serum
LFT’s and IF rose in the subject swine 12 hours after surgery
then normalized at 24–36 hours. Ultrasound revealed gall-
bladder contraction on feeding at 24 hours in both groups.
Both groups showed histological inflammation and micros-
copy in subject swine revealed nanomicelles.
Conclusion: In this short term study, there was no gross
adverse effect on the physiology of the gallbladder. Valida-
tion of these findings as well as more research is needed.
OP-II.57 NEUROENDOCRINE
NEOPLASMS OF THE EXTRAHEPATIC
BILE DUCT: REPORT OF SIX CASES
N. Hong and H. Kim
Department Of Radiology, Asan Medical Center, University
Of Ulsan College Of Medicine, Seoul, SONGPA-GU
Neuroendocrine neoplasms (NENs) are rarely occurred in the
extrahepatic bile duct with a small number of cases reported
to date. We herein report 6 more cases of NENs of the
extrahepatic bile duct which are diagnosed postoperatively in
our single institution over a 12-year period (from January
2001 to June 2012) and discern a set of characteristic features
through retrospective review of their medical records. There
were three male and three female with average age of 59.2
years (range, 41–68 years). The most common presenting
symptoms were right upper quadrant or epigastric discomfort
and obstructive jaundice. According to the recent WHO clas-
sification, five patients were diagnosed neuroendocrine
carcinomas (NECs) and one patient was mixed
adenoneuroendocrine carcinoma (MANEC). Five patients
had their tumors in the common bile duct, and only one
patient in the cystic duct. Morphologically, four tumors were
solid mass, one was cystic mass, and the other one was
segmental duct wall thickening. Most patients received adju-
vant chemotherapy and recurrences were detected in four
patients involving liver, lymph node, pancreas and perito-
neum within 2–7 months after surgery. Only one patient has
survived beyond 3 years without recurrence. NECs of the
extrahepatic bile ducts are such aggressive neoplasms with
poor prognosis and although preoperative diagnoses are not
easy, should be considered in differential diagnosis of malig-
nant bile duct obstruction, to be treated with different strat-
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egy from ordinary bile duct cancer. However, further studies
are needed to comprehend their own clinical behaviors.
OP-II.58 INCIDENTAL GALLBLADDER
CANCER ON CHOLECYSTECTOMY: IS
THERE MORE THAN MEETS THE EYE?
S. Patel, S. Cheek, T. Winston, H. Osman and
D. Jeyarajah
Methodist Dallas, Dallas, TX
Background: Gallbladder cancer (GBC) remains a rare and
underdiagnosed malignancy. This study aims to describe the
experience at non-university tertiary care center (NUTCC)
and to evaluate if patients with incidental GBC on cholecys-
tectomy benefited from further evaluation and radical
resection.
Methods: Patients with GBC from 2006–2013 were retro-
spectively identified in the cancer registry. Patient were
divided into 2 groups; patients with incidental GBC on chol-
ecystectomy prior to referral to our NUTCC (Group A) and
patients who were referred prior to surgical intervention
based on suspicion from radiographic studies (Group B).
Pathological staging was then analyzed.
Results: 36 patients were identified, 23 (64%) in Group A
and 13 (36%) in Group B. 77% were females and 23% were
males. In Group A; 4 (17%) were found to have incidental
stage II GBC after cholecystectomy, 13 (56%) had stage III,
and 6 (26%) had stage IV. All patients in Group A were then
further evaluated at our center; 6 (26%) were deemed
unresectable based on imaging. 17 patients underwent
radical resection and residual disease was found in 10 (58%)
patients. 50% of patients with initial stage II had residual
disease. In Group B 7 (54%) were unresectable and 6 (46%)
had stage III (T3 or N1) disease.
Conclusion: GBC remains an aggressive disease. Majority
of patients with incidental GBC on cholecystectomy will
have further disease, including patients with early disease on
initial pathological staging. All these patients should be
evaluated for radical resection. Furthermore, radiographic
findings suspicious for GBC was an ominous sign for
advanced stage.
OP-II.59 NOVEL STRATEGY FOR
SUSPECTED PT2 GALLBLADDER
CARCINOMA BY LAPAROSCOPIC
APPROACH
O. Itano1, G. Oshima2, M. Shinoda1, M. Kitago1, Y. Abe1,
T. Hibi1, H. Yagi1, S. Aiko2 and Y. Kitagawa1
1Keio University School Of Medicine, Tokyo, TOKYO;
2Eiju General Hospital, Tokyo, TOKYO
Purpose: The purpose of this study was to evaluate the
results of laparoscopic approach for suspected pT2 gallblad-
der carcinoma.
Methods And Procedures: From December 2007 to
January 2013, the laparoscopic approach was performed for
treating 12 patients with suspected pT2 gallbladder carci-
noma. First, staging laparoscopy was done to further exclude
peritoneal dissemination, liver invasion and liver metastases.
After dissection of Calot’s triangle, surgical margin of the
cystic duct was examined by intraoperative pathological
examination. Cholecystectomy and gallbladder bed resection
were performed by laparoscopic procedure. Intraoperative
pathological examination was performed again to confirm
the presence of carcinoma and the depth of invasion. Surgery
was completed when the diagnosis was benign disease. Addi-
tional lymphadenectomy was performed according to the
depth of invasion. Biliary tract reconstruction was performed
through 10-cm subcostal incision.
Results: There was no conversion to laparotomy. For two
patients with benign lesion, surgery finished without
lymphadenectomy. For two patients with T1b carcinoma,
lymphadenectomy was performed at the hepatoduodenal
ligament. Other 8 patients with T2 were added
lymphadenectomy around the pancreas head. Two patients
underwent bile duct resection due to aberrant pancreatico-
biliary duct junction. The mean operative time was 320 ± 123
minutes and the mean blood loss was 96.5 ± 140 ml. There
were no postoperative complications and the mean postop-
erative hospital stay was 6.8 ± 1.8 days. After a mean
follow–up of 21 months, all patients with gallbladder carci-
noma survived without recurrence or metastasis.
Conclusion: Our strategy for suspected pT2 gallbladder car-
cinoma is feasible and safe.
OP-II.60 CHOLECYSTECTOMY IN
CIRRHOTIC PATIENTS. WHEN TO
OPERATE?
L. Sarotto1,2, J. Paleari1,2, H. Todeschini1,2 and P. Ferraina2
1Instituto Quirurgico Del Callao, Capital Federal,
BUENOS AIRES; 2Universidad De Buenos Aires,
University Of Medicine, Capital Federal, BUENOS AIRES
Background: The incidence of vesicular lithiasis in patients
with cirrhosis is high implying higher morbidity and
mortality.The hepatic cirrhosis is a severe risk factor due to
the general patient’s condition and the technical surgical
difficulties.
Ojbective: To assess the experience in our laparoscopic
cholecystectomy ward with cirrhotic patients and to deter-
mine the best time to operate on these patients.
Design: Retrospective and descriptive study.
Material and Method: 24 patients with hepatic cirrhosis
subjected to cholecystectomy due to vesicular condition at
the “ Instituto Quirurgico del Callao” between June 2007 and
June 2013. were included. Each patient was assessed regard-
ing their sex, age, clinical , biochemical, surgical and child’s
classification parameters, post operative evolution, hospital
stay and histological diagnosis.
Results: The group consists of 15 women and 9 men with an
average of 60.2 years. The first cause of cirrhosis was viral
(58,3%). The surgical indications were symptomatic
colelithiasis in 19 patients and severe cholecystitis in 5
patients. The pre-surgical diagnosis for cirrhosis was per-
formed on 18 patients and intraoperative diagnosis was
permormed on 6 patients. 16 patients were subjected to
laparoscopic cholecystectomy. All the patients operated who
had been prediagnosed with cirrhosis presented a type A
Child’s classification. 3 patients presented mild ascities as a
post surgical complications. The average hospital stay was
4 days.
Conclusions: The laparoscopic cholecystectomy is a safe
and efficient method in patients with early and compensated
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cirrhosis. At present, cirrhosis is not a counter – indication
laparoscopic cholecystectomy if performed by experimental
surgeons.
SUNDAY, FEBRUARY 23, 2014,
7:30AM–8:30AM
PARALLEL COMPETITIVE
VIDEOS A LIVER
CV-A.01 TOTALLY LAPAROSCOPIC
RIGHT HEPATECTOMY BY CAUDATE
HEPATOTOMY TECHNIQUE
C. U. Corvera and V. Kuo
University Of California San Francisco, San Francisco,
CA
The patient is a 59 year-old woman with synchronous meta-
static colon cancer to the liver. Cross-sectional imaging
showed several hepatic tumors distributed in the right lobe.
Given the location and distribution, a right hepatectomy was
planned. This video describes our preferred anterior
approach for a formal laparoscopic right hepatectomy– A
generous caudate hepatotomy is used to help gain access to
the main right portal vein. The coronary ligament is incised
and the hepatic veins are exposed. The hilar dissection was
commenced by exposing the right hepatic artery lying pos-
terior to the common hepatic duct. The main RHA is clipped
and divided. The main portal vein was dissected until the
bifurcation is clearly identified. A caudate hepatotomy was
done in order to allow isolation and division of the main RPV
by a single firing of a vascular stapler. The line of demarca-
tion along the interlobar plane was marked using
electrocautery and the parenchymal transection was started.
The caudate hepatotomy was extended further posteriorly
beyond the hilum and then the anterior liver was divided. As
the liver was opened, the right bile duct was transected
intrahepatically. Coursing branches of the middle and right
hepatic veins were also managed intrahepatically using a
vascular stapler. The parenchymal transection plane was
aligned along the right lateral edge of the IVC until the
dissection reached the base of the Right hepatic vein. The
RHV was identified and divided and the right hemi-liver was
mobilized from diaphragm. The specimen was extracted via
a low transverse incision.
CV-A.03 LAPAROSCOPIC RIGHT
POSTERIOR SEGMENT LIVER
RESECTION
M. M. Augustine and T. P. Kingham
Memorial Sloan Kettering Cancer Center, New York,
NEW YORK
The purpose of this video presentation is to highlight one
case from our experience performing laparoscopic, right pos-
terior segment liver resection. We illustrate the postioning of
patient, port placement, and the use of laparoscopic
intraoperative ultrasound to define tumor position and
approach to resection. Through our right side mobilization,
which includes right lateral port placement through the chest,
we show how we can access the right posterior liver. The use
of an ultrasonic generator, bipolar cautery, and stapler for
transection of the liver parenchyma are demonstrated. Lastly,
we present extraction from a transvaginal route when com-
bined with a gynecologic laparoscopic operation.
CV-A.04 ROBOTIC-ASSISTED RIGHT
HEPATECTOMY
E. Vicente, Y. Quijano, B. Ielpo, H. Duran, E. Diaz,
I. Fabra, C. Oliva, S. Olivares, R. Caruso, R. Ceron and
J. Plaza
Sanchinarro University Hospital, Madrid, MADRID
Background: Different technical and technological
advances have significantly reduced the morbidity and mor-
tality of hepatic resection in the past 20 years. It has been
proved that the use of minimally invasive procedures in liver
surgery improved the postoperative comfort of the patient as
well as some perioperative complications, like blood loose.
Among minimally invasive surgeries, laparoscopy has occu-
pied a place of privilege. However, it still has important
limitations that Robotic technique evolved to overcome.
Materials and Methods: We present a Robotic-assisted
right hepatectomy in a patient affected by colorectal liver
metastasis.
Results: It is showed the different steps of the procedure
which includes the liver mobilization and hilar dissection, the
liver transection and right supra-hepatic vein section.
Conclusion: This video shows the efficacy and feasibility of
Robotic liver surgery providing a three dimensional imaging,
a greater instrumental movement and tremor filtering of the
surgeon, thus reducing the minimally invasive surgery related
complexity.
CV-A.05 LAPAROSCOPIC LEFT
HEPATECTOMY COMBINING CUSA AND
HARMONIC SCALPEL DISSECTION
J. B. Conneely, R. Smoot and S. Cleary
Toronto General Hospital, Toronto, oNTARIO
The development and increasing availability of laparoscopic
versions of the so-called ‘energy devices’ for vessel sealing
and division has been a boon to laparoscopic surgeons world-
wide. Liver resection in particular has been aided by the
improved performance and evolving ergonomics of these
devices. However, there remains great benefit to be derived
from the use of the laparoscopic version of the Cavitron
Ultrasonic Surgical Aspirator, or ‘CUSA’, for many years,
the workhorse of open liver resection. Herein, we describe
our technique of parenchymal division during major hepate-
ctomy, for which we employ the combined benefits of the
CUSA and the Harmonic Scalpel. During a formal left hepa-
tectomy, we demonstrate the precise parenchymal dissection
made possible by the laparoscopic CUSA. We also demon-
strate how the use of the Harmonic Scalpel in tandem with
the laparoscopic CUSA can facilitate efficient parenchymal
transection by avoiding unnecessary clip application which
can be slow and may affect the use of laparoscopic staplers.
We propose that this technique of liver resection is safe,
efficient and precise.
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